Physician profile
Abi James
NPI 1568987758
$12,132.59
in general payments reported to CMS, 2019-2025
13 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $565 · 2023: $939 · 2024: $204 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,750 · Travel and Lodging: $4,360 · Food and Beverage: $2,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,750.00 |
| Travel and Lodging | $4,359.94 |
| Food and Beverage | $2,457.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,701.09 | 2023-2025 | |
| Stryker Corporation | $1,815.47 | 2024-2025 | 1788, Spy-Phi System |
| Baxter Healthcare | $536.96 | 2023 | Floseal, Peri-Strips Dry |
| Medtronic, INC. | $278.10 | 2022 | |
| Boston Scientific Corporation | $206.47 | 2022-2024 | |
| Davol INC. | $171.44 | 2023-2024 | Arista Ah Flexitip |
| Reshape Lifesciences INC. | $121.38 | 2023 | |
| Siemens Medical Solutions USA, INC. | $93.50 | 2024 | Acuson Sc2000 Diagnostic Ultrasound System |
| Intra-Sana Laboratories | $74.39 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Convatec INC. | $45.66 | 2022-2023 | |
| Kci USA, INC. | $38.00 | 2022 | |
| Smith+Nephew, INC. | $33.05 | 2022 | |
| Ethicon US, LLC | $17.08 | 2025 | Evarrest, Surgiflo Hemostatic Matrix, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abi James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.